Crossmark Global Holdings’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$338K Buy
2,457
+87
+4% +$12K 0.01% 1049
2025
Q1
$427K Buy
2,370
+63
+3% +$11.4K 0.01% 929
2024
Q4
$362K Buy
2,307
+121
+6% +$19K 0.01% 972
2024
Q3
$398K Buy
2,186
+449
+26% +$81.7K 0.01% 962
2024
Q2
$319K Buy
+1,737
New +$319K 0.01% 1040